tirzepatide liver enzymes Eli Lilly's Zepbound improved scarring in mid-stage MASH study Eli Lilly touts tirzepatide's midstage

BMI 30BMI 27 Mounjaro (MTC)GLP-1) Tirzepatide Tirzepatide-1 (GLP-1) 28 4 30 3 (1)

Doctors swear an oath to first, do no harm, and are expected to use treatments supported by evidence or, at minimum, a plausible expectation of benefit outweighing risks

TWO-HORSE RACE The injectable weight-loss drug market is dominated by Novo Nordisk, which manufactures Ozempic and Wegovy - and its rival Eli Lily, whose best-sellers are Zepbound and Mounjaro

Lancet 385 , 517528 (2015)

Additional research by Stanley and colleagues showed that tesamorelin reduced hepatic (liver) fat by approximately 37% in individuals with fatty liver disease, making it one of the few compounds that addresses both visceral adiposity and its downstream consequence of liver fat accumulation